Page 22 - Solution Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharmaniaga will be the first biggest player in the race of developing its own Malaysian-made halal vaccines by 2024. WITH the vaccine rollout starting to take on more influence throughout the world and even here in Malaysia, it was no surprise that the pace of Malaysia’s own programme has started to flesh out in greater detail. That in turn has seen companies, which have long been entrenched in the healthcare theme, beginning to reveal more developments of their strategies. But more significant news to the investment world in this country was the statement issued by the Securities Commissi...

Despite signing a term sheet to supply 3.5 million doses of a Chinese Covid-19 to the Malaysian government, shares in Solution Group Bhd did not receive the expected boost today. Shares in the engineering and biopharmaceuticals company shed as much as 8.72% or 13 sen this morning. At 10.12am, shares in Solution Group were down 7.38% or 11 sen lower at RM1.38, translating into a market value of RM527.25 million.

“The term sheet agreement is to enable Solbio to enter into a definitive agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine for the prevention of Covid-19. The vaccine is jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences, ” the company said in a filing with Bursa Malaysia. ’s unit Solution Biologics Sdn Bhd (Solbio) said it has signed a term sheet agreement with the Health Ministry to supply Covid-19 vaccines to the government. “The term sheet agreement is to enable Solbio to enter into a defi...

said wholly-owned subsidiary Solution Biologics Sdn Bhd (SolBio) has signed a term sheet agreement with the Ministry of Health (MoH) for the supply of Covid-19 vaccine. "The term sheet agreement, signed on Jan 29, is to enable SolBio to enter into a definitive supply agreement to supply 3.5 million doses of the Recombinant Ad5-nCoV vaccine," the company said in a filing today. The vaccine, Solution Group said, was jointly developed by CanSino Biologics Inc and Beijing Institute of Biotechnology, Academy of Military Medical Sciences. Under the agreement, MoH will purchase 3.5 million vials fr...

IF 2020 is the year of rubber glove manufacturers and technology-related counters, penny stocks deserve at least a notable mention. The penny stock fever on the local bourse has not been seen for at least 20 years since the dotcom bubble burst. The eye-popping share price rally lured long-absent retail investors to the stock market and that, in turn, lifted the daily trading volume to a record high of 27.8 billion shares on Aug 11. At the height of the penny stock fever in August, share prices hitting limit up were not a rare sight. On Aug 7, 12 stocks hit limit up, including HLT Global Bhd,�...